MedPath

Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12608000217303
Lead Sponsor
niversity of the West Indies
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
231
Inclusion Criteria

Type 2 diabetes mellitus subjects without malnutrition or severe complications of the disease (cardiovascular, renal, visual and cerebral), male or female, duration of the disease between 1-10 years, good psychological condition, non-smoker and non-alcoholic. Patient given written consent after provided with sufficient information about participation in the trial.

Exclusion Criteria

Pregnant, high blood pressure, psychiatric disorders, severe heart failure or other acutely life-threatened conditions, severe chronic inflammatory disease, less than 40 years old, renal disease, duration of type 2 diabetes greater than 10 years, newly diagnosed persons with type diabetes.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The fasting blood glucose concentration for each group was determined by using the Reflolux S type 1172115 glucometers. Total cholesterol, triglyceride and high density lipoprotein (HDL) were determined by enzymatic methods. High density lipoprotein was measured after precipitating very low density lipoprotein (VLDL) and low density lipoprotein (LDL) cholesterol in the presence of magnesium ions. The LDL fraction was calculated by the Friedwald formula. <br>Changes in fasting blood glucose, total cholesterol, low density lipoprotein and high density lipoprotein cholesterol from baseline to 6 months.[At baseline, 3 and 6 months]
Secondary Outcome Measures
NameTimeMethod
Malondialdehyde concentration in the serum was measured spectrophotometrically. Protein oxidation is based on the detection of the carbonyl group that appears as a result of the oxidation of lateral chains of certain amino acids. Plasma carbonyl group levels were evaluated following the 2,4-dinitrophenylhydrazine (2,4-DNP) assay. The superoxide dismutase activity was determined by inhibition of pyrogallin and catalase activity was measured by ultraviolet method, based on the transformation of hydrogen peroxide.<br>Changes in Malondialdehyde, protein oxidation, super oxide and catalase activities from baseline to 6 months.[At baseline, 3 and 6 months]
© Copyright 2025. All Rights Reserved by MedPath